former investments

With more than 30,000 successfully completed projects for over 1,000 clients worldwide, the Pharmalex Group draws on over 25 years of experience in regulatory affairs, pharmacovigilance/drug safety, scientific services & development consulting and quality management.  Through the merger of the drug safety experts of YES Pharma Services and the regulatory affairs specialists of PharmaLex, as well as the acquisition of 25 additional specialty service providers mainly in Europe and the USA, the new group now employs over 1,200 experts with expertise in all therapeutic areas and biopharmaceutical products at 40 locations in 19 countries. The combination of local presence with global expertise and capacity makes the Pharmalex model exceptionally flexible and enables customized service solutions in customers’ increasingly complex regulatory environments.


Sector Health
Field Regulatory Affairs
Transaction type Owner Buy-Out, Buy & Build
Country Global